EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Immatics NV's enterprise value is $682.60 Mil.
Immatics NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $58.39 Mil. Therefore, Immatics NV's EV-to-Revenue for today is 11.69.
The historical rank and industry rank for Immatics NV's EV-to-Revenue or its related term are showing as below:
IMTX'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.9 Med: 7.73 Max: 33.05
Current: 11.69
During the past 6 years, the highest EV-to-Revenue of Immatics NV was 33.05. The lowest was 0.90. And the median was 7.73.
IMTX's EV-to-Revenue is ranked worse than 59.42% of 1035
companies
in the Biotechnology industry
Industry Median: 8.07
vs IMTX: 11.69
As of today (2024-05-04), Immatics NV's stock price is $10.77.
Immatics NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.73. Therefore, Immatics NV's PS Ratio for today is 14.73.
Immatics NV EV-to-Revenue Historical Data
The historical data trend for Immatics NV's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Immatics NV's EV-to-Revenue
For the Biotechnology subindustry, Immatics NV's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Immatics NV's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Immatics NV's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Immatics NV's EV-to-Revenue falls into.
Immatics NV's current Enterprise Value is $682.60 Mil.
Immatics NV's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $58.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immatics NV's share price for today is $10.77.
Immatics NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.73.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immatics NV EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Immatics NV's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IMTX has been successfully added to your 